CALCA and neoplasm: Together with the CGRP derivative CGPR (8-37), some molecules belonging to group 2 have been commonly employed as AM antagonists (172, 180), shown to reduce AM-mediated endothelial cell proliferation, migration, angiogenesis, tumor growth, and vascularization (5, 121, 157–159).